益得 6461.TW Value Analysis
TW StockBiotech. & Medical
(No presentation for 6461)
6461 Value Score
3
24
15
Limited Growth
- AI analysis rates 6461 with a lower value score of 2.
- It is mainly due to unstable operating cash flow, along with potential higher debt.
- Over the past 3 months, 6461 has maintained an average value rating of 2.3, slightly lower than the rating of 3.1 over the past 3 years, indicating slight decrease in enterprise value.
- Compared to all stocks in the Biotech. & Medical sector, 6461 has a medium value rating.
6461 Value Reference Factors
The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.
Update to 2024/07/16 (Weekly Update)
6461 Financial Forecast
Unit : TWD
Update to 2025/5/9 (Quarterly Update)
6461 Earnings Table
No related data records
6461 Historical Value Score
You can use historical scores of 3 or above to observe potential performance and make investment decisions.
6461 Value Strategy Backtest
The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.
Entry
Exit
The Backtest Result of 6461 from 2018/03 till Now
- 27.58%
- Cumulative Return
- 3.61%
- Annual Return
- 32.20%
- Volatility
- 0.11
- Sharpe Ratio
Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from March, 2018 to May, 2025. (Total Trades: 1)
| 6461 | Sector | TW Overall Market | |
|---|---|---|---|
| Wining Rate | 100% | 46% | 53% |
| Avg Return | 28.3% | 21.1% | 45.4% |
| Avg Profit | 28.3% | 72.2% | 102.9% |
| Avg Loss | - | -22.4% | -20.3% |
| Avg Risk-Reward Ratio | - | 322.8% | 505.8% |
Update to 2025/5/12 (Daily Update)